Evgeny Kulesskiy

Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

Tea Pemovska, Mika Kontro, Bhagwan Yadav et al. · Cancer Discovery · 2013 · 401 citations · Full text

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda et al. · Scientific Reports · 2014 · 357 citations · Full text

Methods for High-throughput Drug Combination Screening and Synergy Scoring

Liye He, Evgeny Kulesskiy, Jani Saarela et al. · Methods in molecular biology · 2018 · 252 citations · Full text

Hit Identification, Synergy Scoring, Medicine +4

Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin

Maxim M. Bespalov, Yulia Sidorova, Sarka Tumova et al. · The Journal of Cell Biology · 2011 · 198 citations · Full text

Synaptic Transmission, Glycobiology, Immunology +25

PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells

Otto Kauko, Caitlin M. O’Connor, Evgeny Kulesskiy et al. · Science Translational Medicine · 2018 · 152 citations · Full text

Cell Signaling, Medicine, Receptor Tyrosine Kinase +13